FDA Authorizes COVID Drug Pemgarda for High-Risk Patients
WEBApr 5, 2024 · Pemgarda is a type of medicine called pre-exposure prophylaxis (PrEP), which is taken to prevent COVID infection. Anyone with COVID—or who has a known recent exposure to someone with a COVID infection—cannot take Pemgarda.
FDA Approves First Injectable Treatment for HIV Pre-Exposure …
WEBToday, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77...
HIV prevention drugs known as PrEP are highly effective, but ... - CBS News
WEBMar 13, 2024 · It's called pre-exposure prophylaxis, or PrEP, and it is about 99% effective to prevent HIV infection through sexual contact when taken as prescribed. But only about one-third of the 1.2...
Long-acting injectable lenacapavir proves effective in HIV …
WEBJul 26, 2024 · WHO welcomes the news that long-acting injectable lenacapavir as pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV acquisition in women. This represents a significant breakthrough in HIV prevention.
Pre-exposure Prophylaxis - latest research news and features
WEBSep 13, 2024 · In the U.S., sexual and gender minority populations are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) is a key prevention method, but its effectiveness relies on...
Final Recommendation Statement: PrEP for HIV Prevention
WEBAugust 22, 2023 – The U.S. Preventive Services Task Force released today a final recommendation statement on pre-exposure prophylaxis (PrEP) to prevent acquisition of HIV. Healthcare professionals should prescribe PrEP to people at increased risk for HIV.
FDA approves second drug to prevent HIV infection as part of …
WEBFDA approved Descovy in at-risk adults and adolescents for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex.
Task Force Issues Final Recommendation Statement on PrEP for …
WEBAug 23, 2023 · Healthcare professionals should prescribe pre-exposure prophylaxis (PrEP) to people at increased risk for HIV. The U.S. Preventive Services Task Force (Task Force) [on August 22] published a final recommendation statement on pre-exposure prophylaxis (PrEP) for the prevention of HIV.
Pre-Exposure Prophylaxis (PrEP) to Prevent HIV
WEBPre-exposure prophylaxis, or PrEP, is a strategy in which people routinely take one or more antiretroviral drugs to reduce their chances of getting HIV.
PrEP - HIV.gov
WEBSep 25, 2024 · CDC Announces Availability of $7 Million to Accelerate PrEP Uptake in EHE Jurisdictions. 08-16-2024 New CDC funding will support efforts in EHE jurisdictions to increase PrEP access and uptake among priority populations disproportionately affected by …